MEDETALİBEYOĞLU, A. Et Al. 2020. The Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Patients with Multiple Myeloma: A Pilot Study. Istanbul University Institute of Health Sciences Journal of Advanced Research in Health Sciences , vol.3, no.3 , 186-194.

MEDETALİBEYOĞLU, A., Akyüz, N., Bayrakdar, S., Altunkaynak, M., AKPINAR, T. S., & Taşçıoğlu, C., (2020). The Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Patients with Multiple Myeloma: A Pilot Study. Istanbul University Institute of Health Sciences Journal of Advanced Research in Health Sciences , vol.3, no.3, 186-194.

MEDETALİBEYOĞLU, Alpay Et Al. "The Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Patients with Multiple Myeloma: A Pilot Study," Istanbul University Institute of Health Sciences Journal of Advanced Research in Health Sciences , vol.3, no.3, 186-194, 2020

MEDETALİBEYOĞLU, Alpay Et Al. "The Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Patients with Multiple Myeloma: A Pilot Study." Istanbul University Institute of Health Sciences Journal of Advanced Research in Health Sciences , vol.3, no.3, pp.186-194, 2020

MEDETALİBEYOĞLU, A. Et Al. (2020) . "The Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Patients with Multiple Myeloma: A Pilot Study." Istanbul University Institute of Health Sciences Journal of Advanced Research in Health Sciences , vol.3, no.3, pp.186-194.

@article{article, author={Alpay MEDETALİBEYOĞLU Et Al. }, title={The Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Patients with Multiple Myeloma: A Pilot Study}, journal={Istanbul University Institute of Health Sciences Journal of Advanced Research in Health Sciences}, year=2020, pages={186-194} }